View allAll Photos Tagged brainstorming

038

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

2:55 PM

FOLLOW THE GAZE: WHAT WEBCAM EYE-TRACKING CAN TEACH US

Our eyes and the way we look at our screens have the potential to unlock crucial data that can transform the way we are treated. A demonstration of one of the most eye-opening new diagnostic technologies coming down the pike.

 

Dr. Alexandra Papoutsaki, Assistant Professor in Computer Science, Pomona College

 

Photograph by Stuart Isett/Fortune

042

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:30 PM

A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

 

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors

Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

 

Moderator:Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

005

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

3:10 PM

THE BORDERLESS WORLD

If we’ve learned anything over past decades as we shape health care policy, it’s that the lines on the global map are thin and permeable, when they exist at all. From the spread of disease and emerging pathogens to the logistics of drug development and medical manufacturing, borders are increasingly irrelevant. We press some globally minded thinkers on how enterprises can manage the challenges of an increasingly connected planet—and better yet, tap the power of a connected world.

 

Joe Almeida, Chairman, President and CEO, Baxter International

George Barrett, Executive Chairman, Cardinal Health

Michael Milken, Chairman, Milken Institute

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

023

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:40 AM

HOW AI WILL CHANGE MEDICINE

The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.

 

Adrian Aoun, CEO and Founder, Forward

Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health

Julie Sweet, Chief Executive Officer, North America, Accenture

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

009

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

4:40 PM

THE MOTHER OF INVENTION

Necessity isn’t the mother of invention, creativity is. But where do you find the special spark that can help transform a product from merely a “cool” piece of tech to a must-have that can change lives for the better? And, in an age when billions of dollars are being pumped into digital health and medical technology ventures, how can stakeholders identify the most promising innovations? A conversation with some of the most creative minds in the health space.

 

James Park, Co-founder and CEO, Fitbit

Dr. Martine Rothblatt, Chairman and Chief Executive Officer, United Therapeutics Corp.

Moderator: Sue Siegel, Chief Innovation Officer, GE; Chief Executive Officer, GE Ventures

 

Photograph by Stuart Isett/Fortune

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

004

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:45 PM

MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM

Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.

 

Deborah DiSanzo, General Manager, IBM Watson Health

Amy Powell, President, Paramount Television and Digital Entertainment

Bernard J. Tyson, Chairman and CEO, Kaiser Permanente

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

031

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

12:30 PM

HOW TO CHANGE THE COURSE OF A DISEASE

It’s the last frontier: the human brain. When it comes to medical treatment, the brain and central nervous system remain the darkest, most forbidding, realm—even as our knowledge of how the brain and mind work grows by leaps each year. Now, some say we are at the edge of genuine breakthroughs in treatment for diseases that have haunted humankind for generations, from Huntington’s to ALS to Alzheimer’s. Two warriors on the front lines of brain science will share the latest discoveries and discuss what it will take to solve the most complex puzzles of our most complex organ.

Ann Romney, Global Ambassador, Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital

 

Dr. Rudolph Tanzi, Vice Chair of Neurology and Director, Genetics and Aging Research Unit, Massachusetts General Hospital; Professor of Neurology, Harvard Medical School

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

004

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:45 PM

MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM

Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.

 

Deborah DiSanzo, General Manager, IBM Watson Health

Amy Powell, President, Paramount Television and Digital Entertainment

Bernard J. Tyson, Chairman and CEO, Kaiser Permanente

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

005

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

3:10 PM

THE BORDERLESS WORLD

If we’ve learned anything over past decades as we shape health care policy, it’s that the lines on the global map are thin and permeable, when they exist at all. From the spread of disease and emerging pathogens to the logistics of drug development and medical manufacturing, borders are increasingly irrelevant. We press some globally minded thinkers on how enterprises can manage the challenges of an increasingly connected planet—and better yet, tap the power of a connected world.

 

Joe Almeida, Chairman, President and CEO, Baxter International

George Barrett, Executive Chairman, Cardinal Health

Michael Milken, Chairman, Milken Institute

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

031

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

12:30 PM

HOW TO CHANGE THE COURSE OF A DISEASE

It’s the last frontier: the human brain. When it comes to medical treatment, the brain and central nervous system remain the darkest, most forbidding, realm—even as our knowledge of how the brain and mind work grows by leaps each year. Now, some say we are at the edge of genuine breakthroughs in treatment for diseases that have haunted humankind for generations, from Huntington’s to ALS to Alzheimer’s. Two warriors on the front lines of brain science will share the latest discoveries and discuss what it will take to solve the most complex puzzles of our most complex organ.

Ann Romney, Global Ambassador, Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital

 

Dr. Rudolph Tanzi, Vice Chair of Neurology and Director, Genetics and Aging Research Unit, Massachusetts General Hospital; Professor of Neurology, Harvard Medical School

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

003

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:20 PM

U.S. HEALTH CARE: AT THE CROSSROADS

A whole lot has changed since Mark Bertolini, back in 2010, took the helm at Aetna, the (now) $63 billion health insurer: The Affordable Care Act, barely then a law, has launched and (kind of) death spiraled. Opioids have become an acknowledged public health enemy. Wellness has become a corporate mantra. Big data, AI, and blockchain, once mere Silicon Valley buzzwords, have become ways of business that health care companies cannot ignore. The whole system has consolidated, while a formidable crew of outsiders—Google, Apple, Amazon—appear poised to disrupt everything. Bertolini has been at the center of it all—in an intimate and candid conversation with Fortune Editor-in-Chief Clifton Leaf, he’ll talk about navigating one of the nation’s largest health insurers (and the 43rd-largest public company in America) through these waters, and about his final act—Aetna’s transformational deal with CVS—and what it means about the future of health care in America.

 

Mark Bertolini, Chairman and CEO, Aetna Inc.

Interviewer: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

Hermann Josef Hack, GLOBAL BRAINSTORMING, 000401, painting on tarpaulin, 191 x 147 cm, 2000

Resultaten brainstorm Kop van Oost - gehouden op donderdag 23 september olv Ritzo.

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

035

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

PATIENT TRIALS WE CAN ACTUALLY LEARN FROM

Hosted by City of Hope

The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health

 

Matt de Silva, Co-Founder, CEO and Director, Notable Labs

Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator

Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

025

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

10:45 AM

CLIMBING OUT OF LAST PLACE: WEST VIRGINIA AND WELL-BEING

West Virginia consistently ranks last out of the 50 U.S. states when it comes to well-being—with the state levels of obesity, poverty, unemployment, and opioid abuse at or near the worst in the nation. But a surprising ray of hope is on the horizon—a new clinical program designed to help the Mountain State address these issues in a radical way. We offer an early look.

 

Dr. E. Gordon Gee, President, West Virginia University

Dr. Clay Marsh, Vice President and Executive Dean for Health Sciences, West Virginia University

Dr. Ali Rezai, Executive Chair, Vice President and Associate Dean, WVU Rockefeller Neuroscience Institute

 

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

We always head over to my parent's house to take our nieces & hephew trick-or-treating. Our dog always goes along and the kids LOVE that their couson Lucy dresses up. I'm trying to fiure out what Lucy should be for Halloween this year. Head on over and share your ideas.

 

www.ethelgloves.com/magazine/brainstorming-halloween

042

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:30 PM

A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

 

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors

Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

 

Moderator:Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

004

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:45 PM

MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM

Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.

 

Deborah DiSanzo, General Manager, IBM Watson Health

Amy Powell, President, Paramount Television and Digital Entertainment

Bernard J. Tyson, Chairman and CEO, Kaiser Permanente

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

006

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

3:35 PM

IN DEFENSE OF SCIENCE

We live in a time of mind-boggling change and technological advance. Cars drive themselves. Robots perform surgery. Phones can probe the connections of the universe. And humans edit the molecular instructions that shape their very humanity. Yet even as we hurtle through this futuristic present, swept up in discovery and innovation, a surprisingly powerful force is pushing back from the horizon: the fear of science. That force has rallied to challenge the foundation of science itself, undermining scientific research—and, yes, public health and safety. Now, more than ever, the field requires investment and talent, both of which are imperiled. How can we most effectively respond to this assault? What can be done to restore trust in science and fact? And how can we promote investment in science, and draw a new generation of enterprising thinkers to the field?

Dr. Susan Desmond-Hellmann, Chief Executive Officer, Bill & Melinda Gates Foundation

Dr. Margaret Hamburg, President, American Association for the Advancement of Science

Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

Latvian band - "Brainstorm" @Rock Cafe - Tallin. 2010.03.26.

 

www.brainstorm.lv

041

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:05 PM

TAKE TWO TERABYTES AND CALL ME IN THE MORNING: DATA’S GROWING ROLE IN THE MEDICAL TOOL BOX

At the core of precision medicine is precision: the critical need to hit, square on, a moving target in a body chock full of moving targets. To keep the aim sound, we need more than a steady hand, we need data. Smart data, and lots of it. That imperative has driven much of the innovation—and investment—in the current digital health transformation. Entrepreneurs and corporate leaders are now championing the role of big data in everything from drug development to predictive analytics in cancer diagnosis to hospital systems management—and putting billions of dollars behind these efforts. Do the numbers add up, or is the promise of big data yet another false medical miracle?

  

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health

Dr. Kyu Rhee, Vice President and Chief Health Officer, IBM Corporation

Dr. Mona Siddiqui, Chief Data Officer, U.S. Dept. of Health and Human Services

 

Photograph by Stuart Isett/Fortune

Fortune Brainstorm HEALTH 2018

March 19-20, 2018

Laguna Niguel, CA

 

The third Fortune Brainstorm HEALTH conference will be held March 19-20, 2018 in Laguna Niguel. We will again convene a powerful new community of leaders at the forefront of the revolution that is underway in 21st century healthcare.

 

2017 speakers included Joseph R. Biden, Jr., 47th Vice President, United States, CEOs Chip Bergh of Levi Strauss & Co. Mark Bertolini of Aetna, Tom Hayes of Tyson Foods, Arianna Huffington of Thrive Global, John Mackey of Whole Foods, Mike McNamara of Flex, Denise Morrison of Campbell Soup, and Timothy Wentworth of Express Scripts, as well as Duke University Surgical Oncologist (and Time 100 honoree) Dr. Shelley Hwang, Tempus Co-founder and Chair Eric Lefkofsky, Stanford University School of Medicine Dean Dr. Lloyd Minor, Venrock Partner Dr. Bryan Roberts, and Human Longevity Co-founder and Executive Chair Dr. J. Craig Venter. They were joined by our co-chairs—Fortune Editor-in-Chief Clifton Leaf, Time Executive Editor Siobhan O’Connor and Dr. David Agus, one of the world’s most influential physicians.

 

Fortune Brainstorm HEALTH, in association with IBM Watson Health, gathers not only C-suite leaders of top companies, hospitals, insurers, and cutting-edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care. The forum covered four pillars—personal wellness, intervention, research, and the value chain. Our aim is not only to push some boundaries in each of these areas, but also to show how businesses, both established and new, can lead the way. And, yes, as with all of our Brainstorm events, Fortune will disseminate these ideas on our website, in the magazine, on social media, and beyond.

 

Photograph by Stuart Isett/Fortune

021

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:30 AM

THE POWER OF BEDSIDE DATA

A technology that monitors a person’s respiratory rate, heart rate and movement may not seem, at first, like much of an innovation—but consider that EarlySense does this by way of a sensor slipped under your mattress. That allows staff at anywhere from hospitals to nursing homes keep an electronic eye on non-critical patients’ vital signs—in a way that doesn’t have to be invasive. Princess and the Pea: Meet the digital age.

 

Dr. Karissa Price-Rico, COO, EarlySense Ltd.

  

Photograph by Stuart Isett/Fortune

004

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:45 PM

MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM

Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.

 

Deborah DiSanzo, General Manager, IBM Watson Health

Amy Powell, President, Paramount Television and Digital Entertainment

Bernard J. Tyson, Chairman and CEO, Kaiser Permanente

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

038

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

2:55 PM

FOLLOW THE GAZE: WHAT WEBCAM EYE-TRACKING CAN TEACH US

Our eyes and the way we look at our screens have the potential to unlock crucial data that can transform the way we are treated. A demonstration of one of the most eye-opening new diagnostic technologies coming down the pike.

 

Dr. Alexandra Papoutsaki, Assistant Professor in Computer Science, Pomona College

 

Photograph by Stuart Isett/Fortune

brainstorming agreements about digital stuff - on the back of coasters

009

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

4:40 PM

THE MOTHER OF INVENTION

Necessity isn’t the mother of invention, creativity is. But where do you find the special spark that can help transform a product from merely a “cool” piece of tech to a must-have that can change lives for the better? And, in an age when billions of dollars are being pumped into digital health and medical technology ventures, how can stakeholders identify the most promising innovations? A conversation with some of the most creative minds in the health space.

 

James Park, Co-founder and CEO, Fitbit

Dr. Martine Rothblatt, Chairman and Chief Executive Officer, United Therapeutics Corp.

Moderator: Sue Siegel, Chief Innovation Officer, GE; Chief Executive Officer, GE Ventures

 

Photograph by Stuart Isett/Fortune

025

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

10:45 AM

CLIMBING OUT OF LAST PLACE: WEST VIRGINIA AND WELL-BEING

West Virginia consistently ranks last out of the 50 U.S. states when it comes to well-being—with the state levels of obesity, poverty, unemployment, and opioid abuse at or near the worst in the nation. But a surprising ray of hope is on the horizon—a new clinical program designed to help the Mountain State address these issues in a radical way. We offer an early look.

 

Dr. E. Gordon Gee, President, West Virginia University

Dr. Clay Marsh, Vice President and Executive Dean for Health Sciences, West Virginia University

Dr. Ali Rezai, Executive Chair, Vice President and Associate Dean, WVU Rockefeller Neuroscience Institute

 

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

CORPORATE FINANCE IN THE AGE OF CRYPTO

Virtual currency is appearing on the balance sheet of a growing number of companies, including traditional retailers and financial institutions. Yet cryptocurrency’s rollercoaster volatility means new challenges for handling everything from payments to taxes, and more. The CFO of America’s biggest virtual currency exchange and a blockchain-evangelizing e-commerce pioneer offer an inside account.

Patrick Byrne, Chief Executive Officer, Overstock.com

Alesia Haas, Chief Financial Officer, Coinbase Global Inc.

Moderator: Adam Lashinsky, FORTUNE

  

Photography by Rebecca Greenfield/Fortune

092023

Andi Lanuza

 

Brainstormer 2 - Mistaken Judgement, Overgrown, King

 

I decided to come up with a composition with the figure of a king that rarely come to people's minds.

 

So the kings got together, and the Jack of Spades randomly decides to be a king for a day so he came as the King of Spades. Though the King of Diamonds have mistaken him for the true King of Spades, the King of Clubs and the King of Hearts think otherwise, as he is given away by his overgrown moustache.

035

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

PATIENT TRIALS WE CAN ACTUALLY LEARN FROM

Hosted by City of Hope

The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health

 

Matt de Silva, Co-Founder, CEO and Director, Notable Labs

Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator

Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

016

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

7:45 AM

CONCURRENT BREAKFAST SOLUTION SESSIONS

WHY YOU SHOULD SLEEP THROUGH THIS SESSION

The data is real. A good night of sleep can have enormous benefits for our health, well-being, and productivity. Yet, despite the science, many of us continue to forgo the shut-eye we need. Part of the reason is a profound misunderstanding of productivity and where it comes from: While today’s digital world seems to demand that we’re always connected, there’s a smarter, healthier way to get more done. We explore what individuals and companies can do to create a well-rested workplace and what impact that can have on decision making, problem solving, and the bottom line. Can we really change the culture of ALWAYS ON? Rest assured, we can.

 

Liat Ben-Zur, Senior Vice-President, Connected Digital Platforms and Propositions, Royal Philips

Roger Ekirch, Professor of History, Virginia Tech

Dr. Lauren Hale, Professor, Family, Population, and Preventive Medicine; Core Faculty, Program in Public Health, Stony Brook University School of Medicine

Cheri Mah, Research Fellow, Human Performance Center, UC San Francisco

Moderator: David Cloud, CEO, National Sleep Foundation

 

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

042

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

4:30 PM

A SPECIAL CLOSING INTERVIEW: A CONVERSATION WITH KEVIN DURANT AND RICH KLEIMAN

 

Kevin Durant, Partner, The Durant Company; Thirty Five Media, Forward, Golden State Warriors

Rich Kleiman, Co-founder, The Durant Company; Thirty Five Media

 

Moderator:Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

1 2 ••• 52 53 55 57 58 ••• 79 80